Xylooligosaccharide (XOS, 95%)

Food Code: 253151

Prebiotic XOS 95% for foods/supplements; supports Bifidobacterium, regularity, and gut barrier at low daily doses (≈1–4 g).

฿37.09
gram
Min: 0g
pieces
trending_down

Unit price will be cheaper for larger size

The price will be calculated based on the size you enter

Xylooligosaccharide (XOS, 95%) 95% XOS (xylooligosaccharides) is a prebiotic dietary fiber used in foods and supplements to selectively increase beneficial Bifidobacterium and support regularity and gut barrier function.


Benefit Typical study dose* Key human findings High-quality sources
Gut microbiome support (↑ Bifidobacterium) ~1.4–2.8 g/day; 2–8 weeks Consistent bifidogenic effect with good tolerance (little gas/bloating) RSC Publishing; PubMed
Constipation relief 3–10 g/day; ~4 weeks Improved stool form and constipation scores; better QoL PubMed (2023 RCT)
Metabolic markers (early signals) ~4 g/day; 8 weeks Small improvements in glucose, lipids, oxidative stress in select cohorts PubMed
Immune/endotoxemia modulation 1–4 g/day; 2–12 weeks Changes in endotoxemia and immune readouts; stronger with inulin combinations Cambridge Univ. Press; PubMed Central

*Dosing ranges compiled from XOS human studies; responses vary by person. Start low and titrate to comfort.



Mechanistic highlights

  1. Selective fermentation: XOS preferentially nourishes bifidobacteria vs. many commensals.
  2. Short‑chain fatty acids (SCFAs): Fermentation yields acetate/propionate/butyrate that influence motility, epithelial barrier integrity, and metabolic signaling.
  3. Endotoxemia/immune tone: Prebiotic shifts can reduce endotoxin exposure and modulate inflammatory parameters (preliminary in healthy adults).


Safety & practical use

  • Usual supplemental range: 1–4 g/day with food; many aim ~2 g/day.
  • Upper‑dose tolerance: Generally well‑tolerated; sensitive users may experience gas/bloating at higher intakes.
  • How to use: Mix into beverages, smoothies, yogurt, or dry mixes. Start ~1 g/day and increase as tolerated to ~2–3 g/day.
  • Constipation protocols: Trials used 3–10 g/day for ~4 weeks; titrate upward and reassess after 2–4 weeks.
  • Interactions/precautions: Separate from medications by 2–3 hours if concerned; consult if on a low‑FODMAP plan or with GI conditions.

  • white to off‑white powder
  • Room (25-40C)
  • 24 Months from manufacturing or testing date.
  • 1000mg - 4000mg
  • 1000mg - 4000mg
  • Add at last step. Avoid temperature above 40C.
  • Heat Tolerant
  • 0.00 - 0.00
  • -
Test Name Specification
Appearance Powder
Color White or slightly yellowish
Odor Characteristic
Taste Sweet
Foreign matter No visible foreign matter
XOS content (dry basis), % ≥95.0
XOS2–4 content (dry basis), % ≥65.0
pH 3.5–6.0
Moisture, % ≤5.0
Ash, % ≤0.3
Total plate count, CFU/g ≤1000
Coliforms, CFU/g ≤10
Mold, CFU/g ≤25
Yeast, CFU/g ≤25

Xylooligosaccharide (XOS, 95%)

Prebiotic XOS 95% for foods/supplements; supports Bifidobacterium, regularity, and gut barrier at low daily doses (≈1–4 g).

Xylooligosaccharide (XOS, 95%) 95% XOS (xylooligosaccharides) is a prebiotic dietary fiber used in foods and supplements to selectively increase beneficial Bifidobacterium and support regularity and gut barrier function.


Benefit Typical study dose* Key human findings High-quality sources
Gut microbiome support (↑ Bifidobacterium) ~1.4–2.8 g/day; 2–8 weeks Consistent bifidogenic effect with good tolerance (little gas/bloating) RSC Publishing; PubMed
Constipation relief 3–10 g/day; ~4 weeks Improved stool form and constipation scores; better QoL PubMed (2023 RCT)
Metabolic markers (early signals) ~4 g/day; 8 weeks Small improvements in glucose, lipids, oxidative stress in select cohorts PubMed
Immune/endotoxemia modulation 1–4 g/day; 2–12 weeks Changes in endotoxemia and immune readouts; stronger with inulin combinations Cambridge Univ. Press; PubMed Central

*Dosing ranges compiled from XOS human studies; responses vary by person. Start low and titrate to comfort.



Mechanistic highlights

  1. Selective fermentation: XOS preferentially nourishes bifidobacteria vs. many commensals.
  2. Short‑chain fatty acids (SCFAs): Fermentation yields acetate/propionate/butyrate that influence motility, epithelial barrier integrity, and metabolic signaling.
  3. Endotoxemia/immune tone: Prebiotic shifts can reduce endotoxin exposure and modulate inflammatory parameters (preliminary in healthy adults).


Safety & practical use

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...